• Apatinib Boosts Survival in Chinese Patients With Advanced Liver Cancer

  NEW YORK (Reuters Health) - Apatinib improves both overall and progression-free survival in patients with advanced hepatocellular carcinoma that has progressed after previous treatment, according to a

  2021-06-06

• IBD-Associated Colorectal Cancer Genetically Unrelated to Sporadic Type

  NEW YORK (Reuters Health) - Colorectal cancers (CRCs) that evolve from inflammatory bowel disease (IBD) are genetically distinct from sporadic CRC, which may affect prognosis and treatment options, re

  2021-05-12

• Six Pregnancy Complications Flag Later Heart Disease Risk

  Six pregnancy-related complications increase a woman's risk of developing risk factors for cardiovascular disease (CVD) and subsequently developing CVD, the American Heart Association (AHA) says i

  2021-04-09

• Vitamin D Deficiency Linked to Early Cognitive Impairment in MS

  Vitamin D deficiency detected at the time of diagnosis of multiple sclerosis (MS) is associated with cognitive impairment and may also affect disability, according to new research that

  2021-03-09

• Aspirin Linked to Reduced Bladder, Breast Cancer Mortality

  The use of low-dose aspirin among older people shows no effect in reducing the incidence of certain cancer types. However, the treatment — particularly with frequency of at least three times

  2021-02-02

• Gene Expression Different in Allergic, Irritant Contact Dermatitis

  NEW YORK (Reuters Health) - Artificial intelligence (AI) can help identify biomarkers to distinguish between contact dermatitis (CD) due to allergic reactions or to irritants, according to new finding

  2021-01-02

• Youth Depression Tied to a Wide Range of Illnesses, Early Death

  Children and adolescents with depression may be at dramatically increased risk for premature death or an array of diseases later in life, new research suggests.Youths with depression had a significant

  2020-12-17

• Slow Taper off Antimalarial Is Best to Avoid Lupus Flare During Remission

  Slowly tapering off – or remaining on – antimalarial medications can help prevent disease flare in patients with systemic lupus erythematosus (SLE) who've achieved clinical remission for at least

  2020-11-30